Emergency Preparedness and Response
Alignment with U.S. MCM priorities
To ensure that funded research aligns with Public Health Emergency Medical Countermeasures Enterprise priorities, FDA established a Steering Committee for Advancing MCMi Regulatory Science.
Representatives evaluate MCMi Regulatory Science Program research proposals for scientific/technical merit and feasibility and alignment with U.S. MCM priorities. In addition to FDA, members include:
- National Institutes of Health (NIH)
- Centers for Disease Control and Prevention (CDC)
- Biomedical Advanced Research and Development Authority (BARDA)
- U.S. Department of Defense (DoD)
Extramural medical countermeasure (MCM) regulatory science is primarily funded through a Broad Agency Announcement (BAA), which is currently accepting responses until May 22, 2014.